Profil
Hartmut J.
Ehrlich is currently the Chief Executive Officer at Wittycell SAS and Director at Spikimm SAS.
Previously, he was the Chief Executive Officer at Abivax SA from 2013 to 2023 and Head-Global Research & Development at Baxter International, Inc. from 2006 to 2013.
Aktive Positionen von Hartmut Ehrlich
Unternehmen | Position | Beginn |
---|---|---|
Wittycell SAS
Wittycell SAS Pharmaceuticals: MajorHealth Technology Wittycell SAS engages in the research and development, manufacturing, and sale of therapeutic and prophylactic vaccines. It offers novel adjuvant products against infectious diseases and cancer. The company was founded in August 2005 and is headquartered in Reims, France. | Chief Executive Officer | - |
Spikimm SAS | Director/Board Member | - |
Ehemalige bekannte Positionen von Hartmut Ehrlich
Unternehmen | Position | Ende |
---|---|---|
ABIVAX | Chief Executive Officer | 05.05.2023 |
BAXTER INTERNATIONAL INC. | Chief Tech/Sci/R&D Officer | 01.09.2013 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
BAXTER INTERNATIONAL INC. | Health Technology |
ABIVAX | Health Technology |
Private Unternehmen | 2 |
---|---|
Wittycell SAS
Wittycell SAS Pharmaceuticals: MajorHealth Technology Wittycell SAS engages in the research and development, manufacturing, and sale of therapeutic and prophylactic vaccines. It offers novel adjuvant products against infectious diseases and cancer. The company was founded in August 2005 and is headquartered in Reims, France. | Health Technology |
Spikimm SAS |